A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Formoterol Fumarate (FORMOTEROL FUMARATE)

Formoterol Fumarate relaxes airway muscles to relieve bronchospasm in asthma and COPD.

First FDA approval2007-10-01
Generic availableYes · 10 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$10.5M in CY2024 Part D spend21K claims · 6K beneficiaries · 329 plans surveyed

Lowest NADAC
$1.55/unit
10 NDCs benchmarked, lowest of all strengths.
Average NADAC
$3.40
Across all dosage forms in distribution.
Highest NADAC
$10.12
Wide spread — brand-strength NDCs still in market.
Plans with PA
5 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Formoterol Fumarate used for?

Formoterol Fumarate relaxes airway muscles to relieve bronchospasm in asthma and COPD.

Is there a generic for Formoterol Fumarate?

Yes. 10 ANDAs filed at FDA, 10 generic manufacturers currently shipping.

How much does my plan pay for Formoterol Fumarate?

Across 329 Part D plans, Formoterol Fumarate averages $3.40/unit (NADAC). Lowest available: $1.55/unit. Highest in distribution: $10.12/unit.

Is Formoterol Fumarate on the FDA shortage list?

No. Formoterol Fumarate is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

beta2-Adrenergic Agonist4 alternatives in D1
01
Arformoterol
beta2-Adrenergic Agonist
$0.653Lowest NADAC
16Generic mfrs
$8.4MCY24 Part D spend
Compare →
02
Formoterol
beta2-Adrenergic Agonist
$1.55Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Levalbuterol
Brand: Levalbuterol
$0.256Lowest NADAC
7Generic mfrs
$29.7MCY24 Part D spend
Compare →
04
Levalbuterol Inhalation
Brand: levalbuterol inhalation
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (10 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.